门窦血管性疾病:评估与治疗
门窦血管性疾病(PSVD)是2019年提出的术语,指无肝硬化或门静脉血栓形成时出现门静脉高压的一组肝脏疾病。该综述讨论PSVD的临床与组织学特征、影像学评估方法及现有治疗,并指出其自然史、筛查策略、预后和治疗选择仍知之甚少。
要点
- PSVD指无肝硬化或门静脉血栓形成时出现门静脉高压的一组肝脏疾病,可有或无特异性肝组织学表现。
- 新命名整合了Banti病、非肝硬化性门静脉高压、非肝硬化性门静脉纤维化及特发性门静脉高压等旧称。
- PSVD患者可发生食管胃静脉曲张出血和腹水等门静脉高压并发症,但其自然史、筛查策略、预后和治疗选择仍知之甚少。
核心结论
- PSVD新命名有助于整合既往多种术语所描述的疾病知识,但该病自然史、筛查策略、预后和治疗选择仍知之甚少。
- 本综述讨论PSVD的评估方法(临床与组织学特征、影像技术)及现有治疗,并指出新命名带来的挑战和疾病评估中剩余的问题。
研究设计与样本
- 综述,讨论PSVD的评估方法与现有治疗。
主要发现
- PSVD指无肝硬化或门静脉血栓形成时出现门静脉高压的一组肝脏疾病,可有或无特异性肝组织学表现。
- 新命名整合了Banti病、非肝硬化性门静脉高压、非肝硬化性门静脉纤维化及特发性门静脉高压等旧称,并排除了结节病、先天性肝纤维化及Budd-Chiari综合征等病因。
- 该病患病率和识别率不断上升,诊断和治疗进展改善了合并免疫缺陷和自身免疫病等相关疾病患者的预期寿命。
- 与肝硬化相似,PSVD患者可发生食管胃静脉曲张出血和腹水等门静脉高压并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出对PSVD的自然史、筛查策略、预后和治疗选择仍知之甚少。
- 原文指出新命名带来挑战,疾病评估中仍存在未解决的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The term porto-sinusoidal vascular disease (PSVD) was introduced in 2019 to describe a group of liver conditions that can lead to portal hypertension (PH) in the absence of cirrhosis or PVT, with or without specific findings on liver histology. The new nomenclature has facilitated the consolidation of knowledge on diseases previously referred to by various terms, including Banti disease, noncirrhotic portal hypertension, noncirrhotic portal fibrosis, and idiopathic portal hypertension, while excluding certain etiologies like sarcoidosis, congenital hepatic fibrosis, and Budd-Chiari syndrome. The prevalence and recognition of the disorder have been increasing. Advances in diagnostics and treatment have improved life expectancy for patients with associated conditions, such as immunodeficiencies and autoimmune diseases. Similar to cirrhosis, patients with PSVD may experience complications of PH, including variceal bleeding and ascites. However, less is known about its natural history, screening strategies, prognosis, and treatment options. This review discusses methods for assessing PSVD, including clinical and histological features, imaging techniques, and currently available treatments. It also addresses the challenges posed by the new nomenclature and the remaining questions in disease assessment.
引用
- Mironova M, Gopalakrishna H, Koh C, et al. Portal sinusoidal vascular diseases: Assessment and therapy. Hepatology. 2025. PMID: 40194304. doi:10.1097/HEP.0000000000001344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。